Hermann et al. discovered that gemcitabine as standard chemotherapy for pancreatic cancer did not induce apoptosis in the CD133+ subpopulation of the metastatic pancreatic cancer cell line L3.6pl as compared to the CD133- control cells. The gene discussed is PROM1; the disease is pancreatic neoplasm.